William Schultz Recognized as a Litigation Trailblazer by National Law Journal
Zuckerman Spaeder is pleased to announce that the National Law Journal has named partner William B. Schultz a 2020 Litigation Trailblazer. The award recognizes legal professionals across the country who have made significant marks in their sector and represent true agents of change.
Mr. Schultz, who has served in senior roles at the Department of Health and Human Services, the Food and Drug Administration, and the Department of Justice, leads Zuckerman Spaeder’s healthcare practice. Schultz and his team of skilled litigators provide litigation and regulatory support to hospitals, generic drug companies, medical start-ups, public interest organizations, and others – all with the goal of helping bring affordable medical care to patients.
He is recognized as a Trailblazer because his work has involved some of the most vital health issues of the day, including representing public interest organizations and state hospital associations in challenges to the Affordable Care Act and public health groups in advocating for stronger regulation of tobacco products. Most recently, he delivered important wins in support of the federal 340B drug discount program, which meaningfully contributes to the fight for lower-cost medications by providing funds for nonprofit hospitals to serve vulnerable communities.
Asked about where he sees future legal activity in his sector, Mr. Schultz told the National Law Journal that “the massive amount of money spent as part of COVID-19 efforts will result in many fraud investigations by public and private lawyers.”
In addition to his work as an attorney in government and private practice, Mr. Schultz taught at Georgetown University Law Center for ten years and he regularly speaks and writes about health care issues, including recent opinion articles in The Washington Post and The New York Times.